Skip to main content
SpringerLink
Log in

HPV vaccination programmes require careful consideration

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Raffle AE.Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ 335: 375-377, No. 7616, 25 Aug 2007

  2. Franco EL.Commentary: health inequity could increase in poor countries if universal HPV vaccination is not adopted. BMJ 335: 378-379, No. 7616, 25 Aug 2007

  3. Lo B.Human papillomavirus vaccination programmes: need to have a broader perspective than simply increasing uptake of the vaccine. BMJ 335: 357-358, No. 7616, 25 Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HPV vaccination programmes require careful consideration. Pharmacoecon. Outcomes News 536, 3 (2007). https://doi.org/10.2165/00151234-200705360-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705360-00006

Keywords

Search

Navigation